{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T22:13:47Z","timestamp":1787004827536,"version":"build-2736575974"},"reference-count":90,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2012,2,1]],"date-time":"2012-02-01T00:00:00Z","timestamp":1328054400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Seminars in Diagnostic Pathology"],"published-print":{"date-parts":[[2012,2]]},"DOI":"10.1053\/j.semdp.2011.06.002","type":"journal-article","created":{"date-parts":[[2012,1,28]],"date-time":"2012-01-28T13:58:47Z","timestamp":1327759127000},"page":"19-30","source":"Crossref","is-referenced-by-count":22,"title":["Mastocytosis and related disorders"],"prefix":"10.1053","volume":"29","author":[{"given":"April","family":"Chiu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attilio","family":"Orazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1053\/j.semdp.2011.06.002_bib1","series-title":"WHO Classification of Tumours of Haematopoietic and Lymphoid Tissues","first-page":"54","article-title":"Mastocytosis","author":"Horny","year":"2008"},{"key":"10.1053\/j.semdp.2011.06.002_bib2","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: A consensus proposal","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.06.002_bib3","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/0002-9343(91)90214-I","article-title":"Hematologic manifestations of systemic mast cell disease: A prospective study of laboratory and morphologic features and their relation to prognosis","volume":"91","author":"Lawrence","year":"1991","journal-title":"Am J Med"},{"key":"10.1053\/j.semdp.2011.06.002_bib4","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00005792-198811000-00001","article-title":"Systemic mast cell disease","volume":"67","author":"Travis","year":"1988","journal-title":"Medicine (Baltimore)"},{"key":"10.1053\/j.semdp.2011.06.002_bib5","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0190-9622(88)70007-9","article-title":"Bone marrow findings in adult patients with urticaria pigmentosa","volume":"18","author":"Czarnetzki","year":"1988","journal-title":"J Am Acad Dermatol"},{"key":"10.1053\/j.semdp.2011.06.002_bib6","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S0145-2126(01)00044-3","article-title":"Clinical and histopathological aspects of cutaneous mastocytosis","volume":"25","author":"Wolff","year":"2001","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.06.002_bib7","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/modpathol.2009.53","article-title":"The stromal composition of mast cell aggregates in systemic mastocytosis","volume":"22","author":"Chiu","year":"2009","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2011.06.002_bib8","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","article-title":"Systemic mastocytosis in 342 consecutive adults: Survival studies and prognostic factors","volume":"113","author":"Lim","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.06.002_bib9","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1182\/blood-2009-10-249979","article-title":"WHO subvariants of indolent mastocytosis: Clinical details and prognostic evaluation in 159 consecutive adults","volume":"115","author":"Pardanani","year":"2010","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.06.002_bib10","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1016\/j.leukres.2007.04.002","article-title":"Systemic mastocytosis in association with chronic lymphocytic leukemia: A rare diagnosis","volume":"31","author":"Ault","year":"2007","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.06.002_bib11","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1136\/jcp.2003.014860","article-title":"Systemic mastocytosis with associated clonal haematological non-mast cell lineage diseases: A histopathological challenge","volume":"57","author":"Horny","year":"2004","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.semdp.2011.06.002_bib12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1080\/10428190310001615693","article-title":"Bone marrow mastocytosis associated with IgM kappa plasma cell myeloma","volume":"45","author":"Stellmacher","year":"2004","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2011.06.002_bib13","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/path.2677","article-title":"Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD)","volume":"220","author":"Sotlar","year":"2010","journal-title":"J Pathol"},{"key":"10.1053\/j.semdp.2011.06.002_bib14","doi-asserted-by":"crossref","first-page":"3769","DOI":"10.1182\/blood-2009-05-220145","article-title":"Prognostically relevant breakdown of 123 patients with systemic mastocytosis associated with other myeloid malignancies","volume":"114","author":"Pardanani","year":"2009","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.06.002_bib15","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/0046-8177(94)90308-5","article-title":"Systemic mast cell disease presenting with peripheral blood eosinophilia","volume":"25","author":"Miranda","year":"1994","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2011.06.002_bib16","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0025-6196(12)62636-6","article-title":"Mast cell leukemia: Report of a case and review of the literature","volume":"61","author":"Travis","year":"1986","journal-title":"Mayo Clin Proc"},{"key":"10.1053\/j.semdp.2011.06.002_bib17","first-page":"159","article-title":"A case of malignant mastocytosis with circulating mast cell precursors: Biologic and phenotypic characterization of the malignant clone","volume":"10","author":"Baghestanian","year":"1996","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.06.002_bib18","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/ajh.2830340409","article-title":"Malignant mastocytosis with circulating mast cells","volume":"34","author":"Torrey","year":"1990","journal-title":"Am J Hematol"},{"key":"10.1053\/j.semdp.2011.06.002_bib19","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1002\/ajh.21713","article-title":"Myelomastocytic leukemia versus mast cell leukemia versus systemic mastocytosis associated with acute myeloid leukemia: A diagnostic challenge","volume":"85","author":"Arredondo","year":"2010","journal-title":"Am J Hematol"},{"key":"10.1053\/j.semdp.2011.06.002_bib20","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/modpathol.2010.224","article-title":"Aberrant expression of CD30 in neoplastic mast cells in high-grade mastocytosis","volume":"24","author":"Sotlar","year":"2011","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2011.06.002_bib21","doi-asserted-by":"crossref","first-page":"740","DOI":"10.3109\/10428194.2010.550072","article-title":"Aberrant expression of CD30 in aggressive systemic mastocytosis and mast cell leukemia: A differential diagnosis to consider in aggressive hematopoietic CD30-positive neoplasms","volume":"52","author":"Valent","year":"2011","journal-title":"Leuk Lymphoma"},{"key":"10.1053\/j.semdp.2011.06.002_bib22","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1136\/jcp.2006.040857","article-title":"Mast-cell sarcoma of the tibia","volume":"60","author":"Brci\u0107","year":"2007","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.semdp.2011.06.002_bib23","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1097\/00000478-200307000-00019","article-title":"Morphologic and immunophenotypic properties of neoplastic cells in a case of mast cell sarcoma","volume":"27","author":"Chott","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2011.06.002_bib24","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1136\/jcp.39.6.596","article-title":"Mast cell sarcoma of the larynx","volume":"39","author":"Horny","year":"1986","journal-title":"J Clin Pathol"},{"key":"10.1053\/j.semdp.2011.06.002_bib25","first-page":"739","article-title":"Mast cell sarcoma with tissue eosinophilia arising in the ascending colon","volume":"12","author":"Kojima","year":"1999","journal-title":"Mod Pathol"},{"key":"10.1053\/j.semdp.2011.06.002_bib26","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1001\/archinte.1966.00290160058012","article-title":"Solitary mast cell \u201ctumor\u201d of lung","volume":"118","author":"Charrette","year":"1966","journal-title":"Arch Intern Med"},{"key":"10.1053\/j.semdp.2011.06.002_bib27","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1002\/1097-0142(19880515)61:10<2089::AID-CNCR2820611026>3.0.CO;2-9","article-title":"Solitary mast cell tumor of the lung","volume":"61","author":"Kudo","year":"1988","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2011.06.002_bib28","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1007\/s004050050237","article-title":"A solitary manifestation of mastocytosis in the head and neck","volume":"257","author":"Mylanus","year":"2000","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1053\/j.semdp.2011.06.002_bib29","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1002\/1097-0142(196505)18:5<634::AID-CNCR2820180512>3.0.CO;2-K","article-title":"Solitary mast cell granuloma (histiocytoma) of the lung; a histopathologic, tissue culture and time-lapse cinematographic study","volume":"18","author":"Sherwin","year":"1965","journal-title":"Cancer"},{"key":"10.1053\/j.semdp.2011.06.002_bib30","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0145-2126(01)00029-7","article-title":"Diagnosis of mastocytosis: Value of cytochemistry and immunohistochemistry","volume":"25","author":"Li","year":"2001","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.06.002_bib31","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1182\/blood.V91.8.2731.2731_2731_2736","article-title":"Indolent systemic mast cell disease in adults: Immunophenotypic characterization of bone marrow mast cells and its diagnostic implications","volume":"91","author":"Escribano","year":"1998","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.06.002_bib32","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1097\/00000478-199809000-00013","article-title":"Diagnostic value of immunostaining for tryptase in patients with mastocytosis","volume":"22","author":"Horny","year":"1998","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2011.06.002_bib33","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1097\/00000478-200005000-00009","article-title":"Paraffin section immunophenotype of cutaneous and extracutaneous mast cell disease: Comparison to other hematopoietic neoplasms","volume":"24","author":"Yang","year":"2000","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2011.06.002_bib34","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/01.pai.0000173054.83414.22","article-title":"KIT (CD117): a review on expression in normal and neoplastic tissues, and mutations and their clinicopathologic correlation","volume":"13","author":"Miettinen","year":"2005","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"10.1053\/j.semdp.2011.06.002_bib35","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1182\/blood.V80.9.2237.2237","article-title":"Induction of differentiation of human mast cells from bone marrow and peripheral blood mononuclear cells by recombinant human stem cell factor\/kit-ligand in long-term culture","volume":"80","author":"Valent","year":"1992","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.06.002_bib36","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1159\/000048183","article-title":"Abnormal expression of CD antigens in mastocytosis","volume":"127","author":"Escribano","year":"2002","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1053\/j.semdp.2011.06.002_bib37","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1053\/hupa.2001.24319","article-title":"Immunohistochemical properties of bone marrow mast cells in systemic mastocytosis: Evidence for expression of CD2, CD117\/Kit, and bcl-x(L)","volume":"32","author":"Jordan","year":"2001","journal-title":"Hum Pathol"},{"key":"10.1053\/j.semdp.2011.06.002_bib38","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1309\/CX45R79PCU9HCV6V","article-title":"Delineation of patterns of bone marrow mast cell infiltration in systemic mastocytosis: Value of CD25, correlation with subvariants of the disease, and separation from mast cell hyperplasia","volume":"124","author":"Krokowski","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"10.1053\/j.semdp.2011.06.002_bib39","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1097\/01.pas.0000138181.89743.7b","article-title":"CD25 indicates the neoplastic phenotype of mast cells: A novel immunohistochemical marker for the diagnosis of systemic mastocytosis (SM) in routinely processed bone marrow biopsy specimens","volume":"28","author":"Sotlar","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1053\/j.semdp.2011.06.002_bib40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/cyto.b.10072","article-title":"Immunophenotypic analysis of mast cells in mastocytosis: When and how to do it","volume":"58","author":"Escribano","year":"2004","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1053\/j.semdp.2011.06.002_bib41","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.beha.2010.07.003","article-title":"Phenotypic heterogeneity, novel diagnostic markers, and target expression profiles in normal and neoplastic human mast cells","volume":"23","author":"Valent","year":"2010","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1053\/j.semdp.2011.06.002_bib42","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: A prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients","volume":"108","author":"Garcia-Montero","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.06.002_bib43","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.semdp.2011.06.002_bib44","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0301-472X(99)00145-9","article-title":"Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis","volume":"28","author":"Akin","year":"2000","journal-title":"Exp Hematol"},{"key":"10.1053\/j.semdp.2011.06.002_bib45","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S0145-2126(02)00041-3","article-title":"Detection of c-kit point mutation Asp-816 \u2192 Val in microdissected pooled single mast cells and leukemic cells in a patient with systemic mastocytosis and concomitant chronic myelomonocytic leukemia","volume":"26","author":"Sotlar","year":"2002","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.06.002_bib46","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1136\/mp.53.4.188","article-title":"Detection of c-kit mutation Asp 816 to Val in microdissected bone marrow infiltrates in a case of systemic mastocytosis associated with chronic myelomonocytic leukaemia","volume":"53","author":"Sotlar","year":"2000","journal-title":"Mol Pathol"},{"key":"10.1053\/j.semdp.2011.06.002_bib47","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1038\/jid.2009.281","article-title":"Pediatric mastocytosis is a clonal disease associated with D816V and other activating c-KIT mutations","volume":"130","author":"Bodemer","year":"2010","journal-title":"J Invest Dermatol"},{"key":"10.1053\/j.semdp.2011.06.002_bib48","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/S1525-1578(10)60552-1","article-title":"c-kit mutations in patients with childhood-onset mastocytosis and genotype\u2013phenotype correlation","volume":"7","author":"Yanagihori","year":"2005","journal-title":"J Mol Diagn"},{"key":"10.1053\/j.semdp.2011.06.002_bib49","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1073\/pnas.96.4.1609","article-title":"Activating and dominant inactivating c-KIT catalytic domain mutations in distinct clinical forms of human mastocytosis","volume":"96","author":"Longley","year":"1999","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1053\/j.semdp.2011.06.002_bib50","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.gde.2006.12.010","article-title":"KIT mutations in GIST","volume":"17","author":"Fletcher","year":"2007","journal-title":"Curr Opin Genet Dev"},{"key":"10.1053\/j.semdp.2011.06.002_bib51","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1200\/JCO.2007.14.0707","article-title":"Major response to imatinib mesylate in KIT-mutated melanoma","volume":"26","author":"Hodi","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.06.002_bib52","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0002-9440(10)63120-3","article-title":"KIT mutations are common in testicular seminomas","volume":"164","author":"Kemmer","year":"2004","journal-title":"Am J Pathol"},{"key":"10.1053\/j.semdp.2011.06.002_bib53","doi-asserted-by":"crossref","first-page":"3904","DOI":"10.1200\/JCO.2006.06.9500","article-title":"Adverse prognostic significance of KIT mutations in adult acute myeloid leukemia with inv(16) and t(8;21): A Cancer and Leukemia Group B Study","volume":"24","author":"Paschka","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1053\/j.semdp.2011.06.002_bib54","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00277-002-0575-z","article-title":"Mastocytosis: Current concepts in diagnosis and treatment","volume":"81","author":"Escribano","year":"2002","journal-title":"Ann Hematol"},{"key":"10.1053\/j.semdp.2011.06.002_bib55","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.beha.2005.07.010","article-title":"Pathogenesis, clinical features, and treatment advances in mastocytosis","volume":"19","author":"Pardanani","year":"2006","journal-title":"Best Pract Res Clin Haematol"},{"key":"10.1053\/j.semdp.2011.06.002_bib56","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.leukres.2004.05.003","article-title":"Successful treatment of systemic mastocytosis with high-dose interferon-alfa: Long-term follow-up of a case","volume":"29","author":"Butterfield","year":"2005","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.06.002_bib57","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0145-2126(03)00259-5","article-title":"Response to therapy with interferon alpha-2b and prednisolone in aggressive systemic mastocytosis: Report of five cases and review of the literature","volume":"28","author":"Hauswirth","year":"2004","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.06.002_bib58","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1182\/blood-2003-05-1699","article-title":"Cladribine therapy for systemic mastocytosis","volume":"102","author":"Kluin-Nelemans","year":"2003","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.06.002_bib59","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0145-2126(03)00185-1","article-title":"Treatment of systemic mast cell disease with 2-chlorodeoxyadenosine","volume":"28","author":"Pardanani","year":"2004","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.06.002_bib60","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1056\/NEJM200101253440415","article-title":"Treatment of systemic mast-cell disease with cladribine","volume":"344","author":"Tefferi","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2011.06.002_bib61","doi-asserted-by":"crossref","first-page":"784","DOI":"10.5858\/2007-131-784-SMACCA","article-title":"Systemic mastocytosis: A concise clinical and laboratory review","volume":"131","author":"Patnaik","year":"2007","journal-title":"Arch Pathol Lab Med"},{"key":"10.1053\/j.semdp.2011.06.002_bib62","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1016\/S0145-2126(02)00168-6","article-title":"Aggressive systemic mastocytosis and related mast cell disorders: Current treatment options and proposed response criteria","volume":"27","author":"Valent","year":"2003","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.06.002_bib63","doi-asserted-by":"crossref","first-page":"3222","DOI":"10.1182\/blood-2003-11-3816","article-title":"A novel form of mastocytosis associated with a transmembrane c-kit mutation and response to imatinib","volume":"103","author":"Akin","year":"2004","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.06.002_bib64","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.leukres.2005.08.015","article-title":"A novel K509I mutation of KIT identified in familial mastocytosis-in vitro and in vivo responsiveness to imatinib therapy","volume":"30","author":"Zhang","year":"2006","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.06.002_bib65","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1111\/j.1600-0609.2008.01048.x","article-title":"Dasatinib therapy for systemic mastocytosis: Four cases","volume":"80","author":"Purtill","year":"2008","journal-title":"Eur J Haematol"},{"key":"10.1053\/j.semdp.2011.06.002_bib66","doi-asserted-by":"crossref","first-page":"3906","DOI":"10.1158\/1078-0432.CCR-08-0366","article-title":"Phase II study of dasatinib in Philadelphia chromosome-negative acute and chronic myeloid diseases, including systemic mastocytosis","volume":"14","author":"Verstovsek","year":"2008","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semdp.2011.06.002_bib67","first-page":"316","article-title":"KIT inhibitor midostaurin exhibits a high rate of clinically meaningful and durable responses in advanced systemic mastocytosis: Report of a fully accrued phase II trial","volume":"116","author":"Gotlib","year":"2010","journal-title":"ASH Annu Meet Abstracts"},{"key":"10.1053\/j.semdp.2011.06.002_bib68","doi-asserted-by":"crossref","first-page":"6787","DOI":"10.1158\/1078-0432.CCR-05-1064","article-title":"Myelomastocytic leukemia: Evidence for the origin of mast cells from the leukemic clone and eradication by allogeneic stem cell transplantation","volume":"11","author":"Sperr","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1053\/j.semdp.2011.06.002_bib69","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/sj.thj.6200164","article-title":"Myelomastocytic leukemia: Myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells","volume":"3","author":"Valent","year":"2002","journal-title":"Hematol J"},{"key":"10.1053\/j.semdp.2011.06.002_bib70","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/S0145-2126(01)00040-6","article-title":"Myelomastocytic overlap syndromes: Biology, criteria, and relationship to mastocytosis","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.06.002_bib71","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/j.1365-2559.2005.02314.x","article-title":"Evaluation of neoplastic human mast cells by tryptase-immunoelectron microscopy","volume":"48","author":"Samorapoompichit","year":"2006","journal-title":"Histopathology"},{"key":"10.1053\/j.semdp.2011.06.002_bib72","doi-asserted-by":"crossref","first-page":"4322","DOI":"10.1182\/blood.V84.12.4322.bloodjournal84124322","article-title":"Kit ligand\/mast cell growth factor-independent differentiation of mast cells in myelodysplasia and chronic myeloid leukemic blast crisis","volume":"84","author":"Valent","year":"1994","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.06.002_bib73","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1002\/(SICI)1096-8652(199905)61:1<66::AID-AJH12>3.0.CO;2-3","article-title":"Hyperfibrinolysis in a case of myelodysplastic syndrome with leukemic spread of mast cells","volume":"61","author":"Wimazal","year":"1999","journal-title":"Am J Hematol"},{"key":"10.1053\/j.semdp.2011.06.002_bib74","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1046\/j.1365-2141.2003.04362.x","article-title":"Incidence and prognosis of c-KIT and FLT3 mutations in core binding factor (CBF) acute myeloid leukaemias","volume":"121","author":"Care","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1053\/j.semdp.2011.06.002_bib75","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.1038\/sj.leu.2403870","article-title":"Mutations in KIT and RAS are frequent events in pediatric core-binding factor acute myeloid leukemia","volume":"19","author":"Goemans","year":"2005","journal-title":"Leukemia"},{"key":"10.1053\/j.semdp.2011.06.002_bib76","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/j.leukres.2004.10.005","article-title":"Imatinib mesylate in the treatment of core binding factor leukemias with KIT mutations","volume":"29","author":"Cairoli","year":"2005","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.06.002_bib77","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1182\/blood-2005-02-0583","article-title":"Extracellular KIT receptor mutants, commonly found in core binding factor AML, are constitutively active and respond to imatinib mesylate","volume":"106","author":"Cammenga","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.06.002_bib78","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1182\/blood-2005-04-1466","article-title":"KIT-D816 mutations in AML1-ETO-positive AML are associated with impaired event-free and overall survival","volume":"107","author":"Schnittger","year":"2006","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.06.002_bib79","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/j.molonc.2010.04.008","article-title":"High frequency of concomitant mastocytosis in patients with acute myeloid leukemia exhibiting the transforming KIT mutation D816V","volume":"4","author":"Fritsche-Polanz","year":"2010","journal-title":"Mol Oncol"},{"key":"10.1053\/j.semdp.2011.06.002_bib80","doi-asserted-by":"crossref","first-page":"3319","DOI":"10.1182\/blood-2004-06-2068","article-title":"KIT exon 8 mutations associated with core-binding factor (CBF)-acute myeloid leukemia (AML) cause hyperactivation of the receptor in response to stem cell factor","volume":"105","author":"Kohl","year":"2005","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.06.002_bib81","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1182\/blood.V95.2.726","article-title":"C-kit mutations in core binding factor leukemias","volume":"95","author":"Beghini","year":"2000","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.06.002_bib82","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/S0145-2126(01)00041-8","article-title":"Morphologic properties of neoplastic mast cells: Delineation of stages of maturation and implication for cytological grading of mastocytosis","volume":"25","author":"Sperr","year":"2001","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.06.002_bib83","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1159\/000305552","article-title":"Differential diagnoses of systemic mastocytosis in routinely processed bone marrow biopsy specimens: A review","volume":"77","author":"Horny","year":"2010","journal-title":"Pathobiology"},{"key":"10.1053\/j.semdp.2011.06.002_bib84","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1182\/blood.V98.7.2200","article-title":"Expression of mast cell tryptase by myeloblasts in a group of patients with acute myeloid leukemia","volume":"98","author":"Sperr","year":"2001","journal-title":"Blood"},{"key":"10.1053\/j.semdp.2011.06.002_bib85","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.jaci.2007.05.024","article-title":"KIT D816V-associated systemic mastocytosis with eosinophilia and FIP1L1\/PDGFRA-associated chronic eosinophilic leukemia are distinct entities","volume":"120","author":"Maric","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/j.semdp.2011.06.002_bib86","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0145-2126(03)00065-1","article-title":"Eosinophils are derived from the neoplastic clone in patients with systemic mastocytosis and eosinophilia","volume":"27","author":"Pardanani","year":"2003","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.06.002_bib87","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMoa025217","article-title":"A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome","volume":"348","author":"Cools","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1053\/j.semdp.2011.06.002_bib88","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1016\/j.leukres.2005.11.014","article-title":"Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SM-CEL): Detection of FIP1L1\/PDGFRalpha, classification by WHO criteria, and response to therapy with imatinib","volume":"30","author":"Florian","year":"2006","journal-title":"Leuk Res"},{"key":"10.1053\/j.semdp.2011.06.002_bib89","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jaci.2007.03.015","article-title":"Eosinophilia in systemic mastocytosis: Clinical and molecular correlates and prognostic significance","volume":"120","author":"B\u00f6hm","year":"2007","journal-title":"J Allergy Clin Immunol"},{"key":"10.1053\/j.semdp.2011.06.002_bib90","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1182\/blood-2003-05-1627","article-title":"CHIC2 deletion, a surrogate for FIP1L1\u2013PDGFRA fusion, occurs in systemic mastocytosis associated with eosinophilia and predicts response to imatinib mesylate therapy","volume":"102","author":"Pardanani","year":"2003","journal-title":"Blood"}],"container-title":["Seminars in Diagnostic Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257011000876?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0740257011000876?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,12,27]],"date-time":"2021-12-27T00:01:27Z","timestamp":1640563287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0740257011000876"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,2]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2012,2]]}},"alternative-id":["S0740257011000876"],"URL":"https:\/\/doi.org\/10.1053\/j.semdp.2011.06.002","relation":{},"ISSN":["0740-2570"],"issn-type":[{"value":"0740-2570","type":"print"}],"subject":[],"published":{"date-parts":[[2012,2]]}}}